
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
PAREXEL and Datavant, Inc., a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets, announced they are partnering toward clinical study design and operations, as well as the generation of RWE. The collaboration hopes to enable the linking of healthcare data from a variety of real-world and clinical study data.
Read the full release






